α-Amylase/α-Glucosidase-IN-13

α-Amylase/α-Glucosidase-IN-13

• UNSPSC Description: α-Amylase/α-Glucosidase-IN-13 (Compound 5d) is a dual inhibitor of α-Amylase/α-Glucosidase that can be used for diabetes research[1].
• Target Antigen: Amylases; Glycosidase
• Type: Reference compound
• Related Pathways: Metabolic Enzyme/Protease
• Applications: Metabolism-sugar/lipid metabolism
• Field of Research: Metabolic Disease
• Assay Protocol: https://www.medchemexpress.com/α-amylase-α-glucosidase-in-13.html
• Solubility: 10 mM in DMSO
• Smiles: O=C1C2=CC=CC=C2OC3=C1C(C4=CC=C(OC)C=C4)C(C#N)=C(NC(C)=O)O3
• Molecular Weight: 388.37
• References & Citations: [1]Farzaneh E, et al. Pyrano[2,3-b]chromone derivatives as novel dual inhibitors of α-glucosidase and α-amylase: Design, synthesis, biological evaluation, and in silico studies. Bioorg Chem. 2024;145:107207.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported